See every side of every news story
Published loading...Updated

Alternative to Anti-VEGF Shows Safety, Efficacy in Diabetic Macular Edema

Summary by MedPage Today
(MedPage Today) -- A single intravitreal injection of UBX1325 (foselutoclax), a novel senolytic small molecule inhibitor, had a tolerable safety profile and "trends suggestive of potential efficacy" in patients with diabetic macular edema (DME...

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

MedPage Today broke the news in New York, United States on Friday, April 25, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.